The Latest
-
Eargo, Hearx merge into one OTC hearing aid firm, receive $100M boost
Hearx, the maker of Lexie hearing aids, and Eargo competed for the OTC hearing aid market that the FDA created in 2022.
-
3 takeaways from ACC 2025
Medtronic, Abbott and Boston Scientific had updates on their devices used in heart valve disease treatment at the event.
-
HHS overhaul
HHS layoffs characterized by confusion, errors
The sweeping workforce reduction that began Tuesday was made worse by mistakes and poor communication, including directions for some CMS employees to contact a director who died last year.
Updated April 2, 2025 -
Texas judge overturns FDA’s lab developed test regulation, siding with industry groups
The judge vacated the FDA’s final rule, which was strongly opposed by the laboratory industry, and remanded the matter to HHS Secretary Robert F. Kennedy Jr.
-
HHS overhaul
HHS layoffs could imperil medical device cybersecurity, Democrats say
The FDA has 3,500 jobs on the chopping block, which could hinder cybersecurity oversight, Democrats said during a House subcommittee hearing.
-
Bausch + Lomb recalls Envista intraocular lenses over safety risks
J.P. Morgan analysts said it was too early to discuss the financial impact of the recall, but estimated that $70 million to $90 million of revenue could be at risk this year.
-
HHS overhaul
HHS begins layoffs in chaotic fashion
The Trump administration sent out the first round of reduction-in-force notices early Tuesday morning, telling employees the cuts are necessary to improve efficiency.
-
HHS overhaul
‘Everything is word of mouth’: HHS employees face uncertainty in looming Trump layoffs
Many HHS department heads and employees were unaware of plans to fire some 10,000 employees until they were announced Thursday, sources said.
-
FDA OKs first at-home test for 3 STIs
Visby Medical’s at-home diagnostic, which can be purchased without a prescription, tests for chlamydia, gonorrhea and trichomoniasis.
-
Ermath, Michael. (2020). "Individualized Therapies Workshop" [Photograph]. Retrieved from Flickr.
Peter Marks, FDA’s top vaccine official, resigns
In his resignation letter, Marks cited disagreement with HHS Secretary Robert F. Kennedy Jr., who he said pushed “misinformation and lies.”
-
Tandem eyes Medicare coverage expansion for Type 2
CMO Jordan Pinsker said Tandem hopes to expand Medicare coverage of its automated insulin delivery systems using new data shared at ATTD.